期刊文献+

Curcumin inhibits beta-amyloid protein 40/42 expression in the brain in a concentration-and time-dependent manner

Curcumin inhibits beta-amyloid protein 40/42 expression in the brain in a concentration-and time-dependent manner
在线阅读 下载PDF
导出
摘要 Several studies have demonstrated that the amount of beta-amyloid (Aβ) protein in the brain can be lowered by down-regulating Aβ production, promoting Aβ degradation, reducing Aβ oligomerization or deposition, thereby alleviating symptoms of Alzheimer's disease. Curcumin has been known to be a peroxisome proliferator activated receptor gamma (PPARy) agonist and can obviously inhibit Aβ production and oligomerization. This study investigated the effects of curcumin on the G-site APP cleaving enzyme 1 (BACE1) activity and PPARy expression in human neuroblastoma SH-SY5Y cells, and validated the inhibitory effects of curcumin on Aβ40/42 expression in the brain. Results revealed that PPARy mRNA and protein expression in the human neuroblastoma SH-SY5Y cells significantly increased with increasing curcumin concentration and time course (P 〈 0.05); BACE1 mRNA and protein expression and Aβ40/42 production significantly decreased with increasing curcumin concentration and time course (P 〈 0.05). The changes in PPARy and BACE1 expression during Aβ production could be reversed by the PPARy antagonist GW9662. These findings indicate that curcumin reduced Aβ production by activating PPARy expression and inhibiting BACE1 expression in a concentration- and time-dependent manner. Several studies have demonstrated that the amount of beta-amyloid (Aβ) protein in the brain can be lowered by down-regulating Aβ production, promoting Aβ degradation, reducing Aβ oligomerization or deposition, thereby alleviating symptoms of Alzheimer's disease. Curcumin has been known to be a peroxisome proliferator activated receptor gamma (PPARy) agonist and can obviously inhibit Aβ production and oligomerization. This study investigated the effects of curcumin on the G-site APP cleaving enzyme 1 (BACE1) activity and PPARy expression in human neuroblastoma SH-SY5Y cells, and validated the inhibitory effects of curcumin on Aβ40/42 expression in the brain. Results revealed that PPARy mRNA and protein expression in the human neuroblastoma SH-SY5Y cells significantly increased with increasing curcumin concentration and time course (P 〈 0.05); BACE1 mRNA and protein expression and Aβ40/42 production significantly decreased with increasing curcumin concentration and time course (P 〈 0.05). The changes in PPARy and BACE1 expression during Aβ production could be reversed by the PPARy antagonist GW9662. These findings indicate that curcumin reduced Aβ production by activating PPARy expression and inhibiting BACE1 expression in a concentration- and time-dependent manner.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2010年第16期1205-1210,共6页 中国神经再生研究(英文版)
基金 the National Natural Science Foundation of China,No.30600196 the Science Foundation of Chongqing,No.2006BB5042 the Scientific Research Foundation for the Returned Overseas Chinese Scholars,State Education Ministry,No.[2007]1108
关键词 BETA-AMYLOID Alzheimer's disease β-site APP cleaving enzyme 1 CURCUMIN peroxisome proliferator activated receptor gamma beta-amyloid Alzheimer's disease β-site APP cleaving enzyme 1 curcumin peroxisome proliferator activated receptor gamma
  • 相关文献

参考文献35

  • 1Hof PR,Bouras C,Buée L,et al.Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer's disease cases.Acta Neuropathol.1992;85(1):23-30.
  • 2Duyckaerts C,He Y,Seilhean D,et al.Dementia,Alzheimer's disease,Abeta peptide and tau protein.Ann Pathol.1995;15(1):6-10.
  • 3Ross SL,Martin F,Simonet L,et al.Amyloid precursor protein processing in sterol regulatory element-binding protein site 2 protease-deficient Chinese Hamster ovary cell.J Biol Chem.1998;273(25):15309-15312.
  • 4Golde TE,Dickson D,Hutton M.Filling the gaps in the Abeta cascade hypothesis of Alzheimer's disease.Curr Alzheimer Res.2006;3(5):421-430.
  • 5Lemere CA,Masliah E.Can Alzheimer disease be prevented by amyloid-beta immunotherapy? Nat Rev Neurol.2010;6(2):108-119.
  • 6Mancuso C,Bates TE,Butterfield DA,et al.Natural antioxidants in Alzheimer's disease.Expert Opin Investig Drugs.2007;16(12):1921-1931.
  • 7Tanwar V,Sachdeva J,Golechha M,et al.Curcumin protects rat myocardium against isoproterenol-induced ischemic injury:Attenuation of ventricular dysfunction through increased expression of Hsp27 along with strengthening antioxidant defense system.J Cardiovasc Pharmacol.2010;55(4):377-384.
  • 8Baghdasaryan A,Claudel T,Kosters A,et al.Curcumin improves sclerosing cholangitis in Mdr2-/-mice by inhibiting of cholangiocyte inflammatory response and portal myofibroblest proliferation.Gut.2010;59(4):521-530.
  • 9Kalvodova L,Kahya N,Schwille P,et al.Lipids as modulators of proteolytic activity of BACE:involvement of cholesterol,glycosphingolipids,and anionic phospholipids in vitro.J Biol Chem.2005;280(11):36815-36823.
  • 10Sahlin C,Pettersson FE,Nilsson LN,et al.Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease.Eur J Neurosci.2007;26(4):882-889.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部